Progressive multiple sclerosis: from pathogenic mechanisms to treatment
J Correale, MI Gaitán, MC Ysrraelit, MP Fiol - Brain, 2017 - academic.oup.com
During the past decades, better understanding of relapsing-remitting multiple sclerosis
disease mechanisms have led to the development of several disease-modifying therapies …
disease mechanisms have led to the development of several disease-modifying therapies …
Exercise in patients with multiple sclerosis
RW Motl, BM Sandroff, G Kwakkel, U Dalgas… - The lancet …, 2017 - thelancet.com
Exercise can be a beneficial rehabilitation strategy for people with multiple sclerosis to
manage symptoms, restore function, optimise quality of life, promote wellness, and boost …
manage symptoms, restore function, optimise quality of life, promote wellness, and boost …
Comorbidity in multiple sclerosis
M Magyari, PS Sorensen - Frontiers in Neurology, 2020 - frontiersin.org
Comorbidities in patients with multiple sclerosis (MS) has become an area of increasing
interest in the recent years. A comorbidity is defined as any additional disease that coexists …
interest in the recent years. A comorbidity is defined as any additional disease that coexists …
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …
Objective: The objective of this review is to estimate the incidence and prevalence of …
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
R Geraldes, O Ciccarelli, F Barkhof… - Nature Reviews …, 2018 - nature.com
MRI red flags proposed over a decade ago by the European Magnetic Resonance Network
in MS (MAGNIMS) have guided clinicians in the diagnosis of multiple sclerosis (MS) …
in MS (MAGNIMS) have guided clinicians in the diagnosis of multiple sclerosis (MS) …
The role of diet in multiple sclerosis: A review
S Esposito, S Bonavita, M Sparaco, A Gallo… - Nutritional …, 2018 - Taylor & Francis
Multiple sclerosis (MS) is a multifactorial, inflammatory, and neurodegenerative disease of
the central nervous system, where environmental factors interact with genetic susceptibility …
the central nervous system, where environmental factors interact with genetic susceptibility …
[PDF][PDF] Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
JJ Cerqueira, DAS Compston, R Geraldes… - Journal of Neurology …, 2018 - jnnp.bmj.com
The management of multiple sclerosis (MS) has been a neurology success story for the past
25 years. Advances in understanding of the disease mechanisms and the dynamic nature of …
25 years. Advances in understanding of the disease mechanisms and the dynamic nature of …
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications
L Hauer, J Perneczky, J Sellner - Journal of Neurology, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system
which is associated with numerous comorbidities. These include cardiovascular disease …
which is associated with numerous comorbidities. These include cardiovascular disease …
Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors
Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people.
Comorbid disorders such as depression, anxiety and hypertension are common and can …
Comorbid disorders such as depression, anxiety and hypertension are common and can …
Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England
R Palladino, RA Marrie, A Majeed… - JAMA neurology, 2020 - jamanetwork.com
Importance People with multiple sclerosis (MS) are associated with an increased risk of
cardiovascular disease and mortality; however, evidence from population-based studies is …
cardiovascular disease and mortality; however, evidence from population-based studies is …